Filing Details

Accession Number:
0001140361-15-041230
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-13 17:20:23
Reporting Period:
2015-11-11
Filing Date:
2015-11-13
Accepted Time:
2015-11-13 17:20:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70318 Tenet Healthcare Corp THC Services-General Medical & Surgical Hospitals, Nec (8062) 952557091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1138995 Glenview Capital Management, Llc 767 Fifth Avenue
44Th Floor
New York NY 10153
No No Yes No
1228603 M Lawrence Robbins 767 Fifth Avenue
44Th Floor
New York NY 10153
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.05 Par Value Acquisiton 2015-11-11 500,000 $32.86 17,490,230 No 4 P Indirect See footnotes 1 and 2
Common Stock, $0.05 Par Value Acquisiton 2015-11-12 250,000 $32.28 17,740,230 No 4 P Indirect See footnotes 1 and 2
Common Stock, $0.05 Par Value Acquisiton 2015-11-13 150,000 $32.01 17,890,230 No 4 P Indirect See footnotes 1 and 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes 1 and 2
No 4 P Indirect See footnotes 1 and 2
No 4 P Indirect See footnotes 1 and 2
Footnotes
  1. These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were purchased for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
  2. Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  3. This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on November 11, 2015 within a $1.00 range. The actual prices for these transactions range from $32.515 to $33.025, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  4. This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on November 12, 2015 within a $1.00 range. The actual prices for these transactions range from $31.99 to $32.395, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
  5. This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on November 13, 2015 within a $1.00 range. The actual prices for these transactions range from $31.805 to $32.22, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.